# 2025-17819: DEA Reviews Application to Import Controlled Substances

2025-17819, Importer of Controlled Substances Application: Catalent Greenville, Inc., is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-09-16 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-17819
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-17819
- Title: Importer of Controlled Substances Application: Catalent Greenville, Inc.
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 44713
- Published: 2025-09-16
- Effective: unknown
- Comments close: 2025-10-16
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

DEA Reviews Application to Import Controlled Substances

## Summary

Catalent Greenville, Inc. wants to become an official importer of certain controlled substances. This means they’ll be allowed to bring in specific drugs that need special handling. If approved, it could affect companies and regulators watching drug imports, with no immediate cost or deadline changes announced.

## Abstract

Catalent Greenville, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-17819 on federalregister.gov](https://www.federalregister.gov/documents/2025/09/16/2025-17819/importer-of-controlled-substances-application-catalent-greenville-inc)
- [2025-17819 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-09-16/pdf/2025-17819.pdf)

## Related
- [Previous: 2025-17818, Advisory Committee on Cemeteries and Memorials, Notice of Meeting, Amended](https://policyrisk.com/federal-register/2025-17818)
- [Next: 2025-17820, Freedom of Information Act “Still Interested” Inquiry](https://policyrisk.com/federal-register/2025-17820)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-17819 (as of 2026-06-08).
